Literature DB >> 6402874

Thyroxine and triiodothyronine levels in Snell mice.

S van Buul-Offers, W H Hackeng, W Schopman.   

Abstract

Since no data are available concerning thyroid hormone levels in Snell dwarf mice from birth on, a cross-sectional study was performed of L-thyroxine (T4) and L-triiodothyronine (T3) levels in blood or serum as a function of age of several litters, starting at birth. In normal Snell mice T4 levels in blood and serum are changing with age. T4 increases during the first 2 weeks of age and declines thereafter, until adult levels of about 50 nmol/l are reached at 21 days of age. Serum T3 values are in the range of 2-3 nmol/l. They do not show such an age-related pattern. From birth on in each litter there was a clear separation between animals with low T4 levels in blood and the others. This separation was possible at all subsequent days until 9 days of age, when dwarfs can be recognized by eye. Above that age the low T4 values were associated with dwarfism. This suggests that dwarfs are hypothyroid already at birth. Serum T3 in dwarfs falls below the normal range only after 4 weeks of age, resulting in a lower T4/T3 ratio than normal. The half life time of exogenous T4 in serum of dwarfs is in the range of 13-18 h and not different from normal. For T3 t1/2 is 9.5-11.1 h. Dwarf mice become euthyroid by treatment with 0.1 microgram T4 per day. 1 microgram T4 was needed to reach a physiological level of T3. These data suggest that the peripheral conversion of T4 to T3 is slower in dwarfs than in normals. Treatment with hGH, prolactin, glucagon, insulin, testosterone and oestradiol had no influence on serum T4. As expected TSH was stimulatory. Similar results were obtained for serum T3, with the exception of prolactin which caused slightly increased levels of serum T3.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402874     DOI: 10.1530/acta.0.1020396

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  7 in total

1.  Immunocytochemistry of TSH cells during development of the dwarf mutant mouse.

Authors:  D B Wilson; D P Wyatt
Journal:  Anat Embryol (Berl)       Date:  1986

2.  NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways.

Authors:  Kristen R Vella; Preeti Ramadoss; Francis S Lam; Jamie C Harris; Felix D Ye; Paul D Same; Nicholas F O'Neill; Eleftheria Maratos-Flier; Anthony N Hollenberg
Journal:  Cell Metab       Date:  2011-11-17       Impact factor: 27.287

3.  Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness.

Authors:  Roberto Rocchi; Hiroaki Kimura; Shey-Cherng Tzou; Koichi Suzuki; Noel R Rose; Aldo Pinchera; Paul W Ladenson; Patrizio Caturegli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

4.  Linking hematopoiesis to endochondral skeletogenesis through analysis of mice transgenic for collagen X.

Authors:  Olena Jacenko; Douglas W Roberts; Michelle R Campbell; Patricia M McManus; Catherine J Gress; Zhuliang Tao
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

5.  Biosynthesis of 3-iodothyronamine (T1AM) is dependent on the sodium-iodide symporter and thyroperoxidase but does not involve extrathyroidal metabolism of T4.

Authors:  Sarah A Hackenmueller; Maja Marchini; Alessandro Saba; Riccardo Zucchi; Thomas S Scanlan
Journal:  Endocrinology       Date:  2012-09-04       Impact factor: 4.736

6.  Hereditary pituitary dwarfism in mice affects skeletal and cardiac myosin isozyme transitions differently.

Authors:  R G Whalen; M Toutant; G S Butler-Browne; S C Watkins
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

7.  Failure of thyroid hormone treatment to prevent inflammation-induced white matter injury in the immature brain.

Authors:  Anne-Laure Schang; Juliette Van Steenwinckel; Didier Chevenne; Marten Alkmark; Henrik Hagberg; Pierre Gressens; Bobbi Fleiss
Journal:  Brain Behav Immun       Date:  2013-11-12       Impact factor: 7.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.